Population Pharmacokinetics, Exposure–Response, and Probability of Target Attainment 1 Analyses for Tedizolid in Adolescent Patients With Acute Bacterial Skin and Skin

[1]  D. Sahm,et al.  Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe. , 2017, Diagnostic microbiology and infectious disease.

[2]  D. Nicolau,et al.  Comparative In Vivo Efficacies of Tedizolid in Neutropenic versus Immunocompetent Murine Streptococcus pneumoniae Lung Infection Models , 2016, Antimicrobial Agents and Chemotherapy.

[3]  E. Ludwig,et al.  Tedizolid Population Pharmacokinetics, Exposure Response, and Target Attainment , 2014, Antimicrobial Agents and Chemotherapy.

[4]  Elaine Wong,et al.  Tedizolid phosphate (sivextro): a second-generation oxazolidinone to treat acute bacterial skin and skin structure infections. , 2014, P & T : a peer-reviewed journal for formulary management.

[5]  S. Flanagan,et al.  Single- and Multiple-Dose Pharmacokinetics and Absolute Bioavailability of Tedizolid , 2014, Pharmacotherapy.

[6]  G. Drusano,et al.  Use of pharmacokinetic/pharmacodynamic systems analyses to inform dose selection of tedizolid phosphate. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Anita F. Das,et al.  Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial. , 2013, JAMA.

[8]  W. Craig,et al.  Comparative Pharmacodynamics of the New Oxazolidinone Tedizolid Phosphate and Linezolid in a Neutropenic Murine Staphylococcus aureus Pneumonia Model , 2012, Antimicrobial Agents and Chemotherapy.

[9]  D. Nicolau,et al.  Pulmonary Disposition of Tedizolid following Administration of Once-Daily Oral 200-Milligram Tedizolid Phosphate in Healthy Adult Volunteers , 2012, Antimicrobial Agents and Chemotherapy.

[10]  A. Louie,et al.  Impact of Granulocytes on the Antimicrobial Effect of Tedizolid in a Mouse Thigh Infection Model , 2011, Antimicrobial Agents and Chemotherapy.

[11]  G. Drusano,et al.  In Vivo Pharmacodynamics of Torezolid Phosphate (TR-701), a New Oxazolidinone Antibiotic, against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Strains in a Mouse Thigh Infection Model , 2011, Antimicrobial Agents and Chemotherapy.

[12]  G. Zurenko,et al.  In Vitro Activity of TR-700, the Active Ingredient of the Antibacterial Prodrug TR-701, a Novel Oxazolidinone Antibacterial Agent , 2009, Antimicrobial Agents and Chemotherapy.

[13]  J. Finn,et al.  In Vitro Activity of TR-700, the Antibacterial Moiety of the Prodrug TR-701, against Linezolid-Resistant Strains , 2008, Antimicrobial Agents and Chemotherapy.